Literature DB >> 22067540

Effectively managing chemotherapy-induced nausea and vomiting.

Janice Middleton1, Elaine Lennan.   

Abstract

This article examines the unpleasant side effect of chemotherapy-induced nausea and vomiting (CINV). What was once the main reason for withdrawing from treatment is now much more tolerable owing to the advent of modern antiemetics. However, because of the improvements in these antiemetics, the focus on CINV appears to have lapsed. Despite this, some patients continue to experience problems and under-report this side effect. This article looks at the mechanism of CINV and clarifies terminology and definitions surrounding it. Risk factors are discussed and management strategies advised, including appropriateness of modern antiemetics and non-pharmacological strategies. To conclude, a brief look at nursing implications and self-management strategies are explored.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22067540     DOI: 10.12968/bjon.2011.20.Sup10.S7

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  3 in total

Review 1.  Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA).

Authors:  Vito Lorusso; Anna Russo; Francesco Giotta; Paolo Codega
Journal:  Core Evid       Date:  2020-07-27

2.  Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea.

Authors:  So Hyun Bae; Min-Jung Park; Min Mi Lee; Tae Min Kim; Se-Hoon Lee; Sung Yun Cho; Young-Hoon Kim; Yu Jung Kim; Chul-Kee Park; Chae-Yong Kim
Journal:  J Korean Med Sci       Date:  2014-07-11       Impact factor: 2.153

Review 3.  Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron.

Authors:  Vito Lorusso
Journal:  Ther Clin Risk Manag       Date:  2016-06-07       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.